• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上调的自分泌血管内皮生长因子 (VEGF)/VEGF 受体-2 环可防止血管瘤衍生的内皮细胞凋亡。

Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells.

机构信息

Division of Oncology, Department of Pediatric Surgery, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.

出版信息

Br J Dermatol. 2014 Jan;170(1):78-86. doi: 10.1111/bjd.12592.

DOI:10.1111/bjd.12592
PMID:24033364
Abstract

BACKGROUND

The autocrine vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR)-2 loop is required to maintain the transformed phenotype of many tumours, in part, by preventing apoptotic cell death in response to many different stimuli. However, it is unclear whether constitutive VEGF/VEGFR-2 activation in haemangioma-derived endothelial cells (HaemECs) can lead to a general suppression of apoptosis.

OBJECTIVES

The objective of this study was to investigate whether the autocrine VEGF loop promotes HaemEC survival via its receptor, VEGFR-2.

METHODS

HaemECs and human umbilical vein endothelial cells (HUVECs) were serum-starved for 12-48 h. Cell apoptosis was measured. The potential mechanisms of VEGF/VEGFR-2-induced HaemEC survival were investigated, and the role of the autocrine VEGF/VEGFR-2 loop in preventing propranolol-induced apoptotic HaemEC death was also analysed.

RESULTS

Compared with HUVECs, HaemECs showed increased resistance to apoptosis induced by serum starvation. Upregulated VEGF/VEGFR-2 signalling in HaemECs induced an autocrine signalling loop, which resulted in Akt activation. Furthermore, this activation of Akt was necessary for VEGF/VEGFR-2-induced protection against serum deprivation-induced HaemEC apoptosis. In addition, Bcl-2, which functions as an anti-apoptotic factor and direct downstream target of PI3K/Akt, was decreased by the inhibition of VEGF/VEGFR-2, which led to an increase in caspase-3 activity, caspase-9 activity and HaemEC apoptosis. Moreover, HaemECs acquired greater resistance to propranolol treatment than HUVECs, whereas inhibition of VEGF/VEGFR-2 signalling in HaemECs sensitized these cells to propranolol-induced apoptosis.

CONCLUSIONS

Our results demonstrate that upregulation of the autocrine VEGF/VEGFR-2 loop can induce general resistance to apoptotic stimuli in HaemECs.

摘要

背景

自分泌血管内皮生长因子 (VEGF)/VEGF 受体 (VEGFR)-2 环对于维持许多肿瘤的转化表型是必需的,部分原因是通过防止对许多不同刺激的凋亡细胞死亡。然而,尚不清楚血管生成性血管瘤衍生的内皮细胞 (HaemECs) 中的组成性 VEGF/VEGFR-2 激活是否会导致普遍抑制细胞凋亡。

目的

本研究旨在探讨自分泌 VEGF 环是否通过其受体 VEGFR-2 促进 HaemEC 存活。

方法

将 HaemECs 和人脐静脉内皮细胞 (HUVECs) 饥饿血清 12-48 小时。测量细胞凋亡。研究了 VEGF/VEGFR-2 诱导 HaemEC 存活的潜在机制,并分析了自分泌 VEGF/VEGFR-2 环在防止普萘洛尔诱导的凋亡 HaemEC 死亡中的作用。

结果

与 HUVECs 相比,HaemECs 对血清饥饿诱导的凋亡表现出更高的抵抗力。HaemECs 中上调的 VEGF/VEGFR-2 信号诱导了一个自分泌信号环,导致 Akt 激活。此外,VEGF/VEGFR-2 诱导的 Akt 激活对于防止血清剥夺诱导的 HaemEC 凋亡是必需的。此外,作为抗凋亡因子和 PI3K/Akt 的直接下游靶标的 Bcl-2 被 VEGF/VEGFR-2 抑制下调,导致 caspase-3 活性、caspase-9 活性和 HaemEC 凋亡增加。此外,HaemECs 对普萘洛尔治疗的抵抗力比 HUVECs 更强,而 HaemECs 中 VEGF/VEGFR-2 信号的抑制使这些细胞对普萘洛尔诱导的凋亡敏感。

结论

我们的研究结果表明,自分泌 VEGF/VEGFR-2 环的上调可以诱导 HaemEC 对凋亡刺激的普遍抵抗力。

相似文献

1
Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells.上调的自分泌血管内皮生长因子 (VEGF)/VEGF 受体-2 环可防止血管瘤衍生的内皮细胞凋亡。
Br J Dermatol. 2014 Jan;170(1):78-86. doi: 10.1111/bjd.12592.
2
Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.普萘洛尔通过下调PI3K/Akt/eNOS/VEGF通路诱导血管瘤细胞消退。
Pediatr Blood Cancer. 2015 Aug;62(8):1414-20. doi: 10.1002/pbc.25453. Epub 2015 Mar 1.
3
Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.乳腺癌中的自分泌血管内皮生长因子信号传导。来自体外细胞系和原发性乳腺癌培养物的证据。
Angiogenesis. 2005;8(3):197-204. doi: 10.1007/s10456-005-9010-0. Epub 2005 Nov 19.
4
Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.神经纤毛蛋白-1 调节血管内皮生长因子诱导的多聚(ADP-核糖)聚合酶,从而减少脑血管细胞凋亡。
Neurobiol Dis. 2013 Nov;59:111-25. doi: 10.1016/j.nbd.2013.06.009. Epub 2013 Jun 28.
5
Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.内皮祖细胞可能抑制肺微血管内皮细胞凋亡:肺动脉高压细胞治疗的新见解。
Cytotherapy. 2009;11(4):492-502. doi: 10.1080/14653240902960460.
6
Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.内脂素通过丝裂原活化蛋白激酶(MAPK)和磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/Akt)信号通路诱导人内皮细胞产生血管内皮生长因子(VEGF)和基质金属蛋白酶-2/9(MMP-2/9):内脂素诱导血管生成的新见解
Cardiovasc Res. 2008 May 1;78(2):356-65. doi: 10.1093/cvr/cvm111. Epub 2007 Dec 18.
7
The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade.表皮生长因子受体1(ErbB1)阻断可增强血管内皮生长因子受体抑制的抗肿瘤和抗血管生成活性。
Clin Cancer Res. 2005 Jun 15;11(12):4521-32. doi: 10.1158/1078-0432.CCR-04-1954.
8
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells.血管内皮生长因子(VEGF)在肾小管上皮细胞中的自分泌和旁分泌功能。
Kidney Int. 2005 Feb;67(2):449-57. doi: 10.1111/j.1523-1755.2005.67101.x.
9
Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.血管内皮生长因子受体-1通过抑制Akt的过度激活来调节出生后的血管生成。
Circ Res. 2008 Aug 1;103(3):261-8. doi: 10.1161/CIRCRESAHA.108.174128. Epub 2008 Jun 26.
10
The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.自分泌血管内皮生长因子-A(VEGF-A)和血管内皮生长因子-C(VEGF-C)的平衡决定了足细胞的存活。
Am J Physiol Renal Physiol. 2009 Dec;297(6):F1656-67. doi: 10.1152/ajprenal.00275.2009. Epub 2009 Oct 14.

引用本文的文献

1
Neuroreceptor Inhibition by Clozapine Triggers Mitohormesis and Metabolic Reprogramming in Human Blood Cells.氯氮平通过抑制神经受体触发人血细胞中的 mitohormesis 和代谢重编程。
Cells. 2024 Apr 29;13(9):762. doi: 10.3390/cells13090762.
2
PKCε activator protects hippocampal microvascular disruption and memory defect in 3×Tg-Alzheimer's disease mice with cerebral microinfarcts.蛋白激酶Cε激活剂可保护伴有脑微梗死的3×Tg阿尔茨海默病小鼠的海马微血管破坏和记忆缺陷。
Front Aging Neurosci. 2023 Dec 15;15:1272361. doi: 10.3389/fnagi.2023.1272361. eCollection 2023.
3
Association of Apolipoprotein E4-related Microvascular Disease in the Alzheimer's Disease Hippocampal CA1 Stratum Radiatum.
载脂蛋白 E4 相关的微血管病与阿尔茨海默病海马 CA1 放射层的关系。
Neuroscience. 2023 Aug 21;526:204-222. doi: 10.1016/j.neuroscience.2023.06.019. Epub 2023 Jun 28.
4
Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.靶向磷酸果糖激酶-4 抑制因子 FB3(PFKFB3)阻断糖酵解可抑制婴幼儿血管瘤的发展。
J Transl Med. 2023 Feb 6;21(1):85. doi: 10.1186/s12967-023-03932-y.
5
Infantile hepatic hemangiomas: looking backwards and forwards.婴儿肝血管瘤:回顾与展望
Precis Clin Med. 2022 Feb 11;5(1):pbac006. doi: 10.1093/pcmedi/pbac006. eCollection 2022 Mar.
6
HIV Promotes Neurocognitive Impairment by Damaging the Hippocampal Microvessels.HIV 通过损伤海马微血管促进神经认知障碍。
Mol Neurobiol. 2022 Aug;59(8):4966-4986. doi: 10.1007/s12035-022-02890-8. Epub 2022 Jun 4.
7
Proanthocyanidins as a Potential Novel Way for the Treatment of Hemangioma.原花青素作为治疗血管瘤的一种潜在新方法。
Biomed Res Int. 2021 Jan 2;2021:5695378. doi: 10.1155/2021/5695378. eCollection 2021.
8
Microarray expression profile of mRNAs and long noncoding RNAs and the potential role of PFK-1 in infantile hemangioma.婴儿血管瘤中mRNA和长链非编码RNA的微阵列表达谱及磷酸果糖激酶-1的潜在作用
Cell Div. 2021 Jan 11;16(1):1. doi: 10.1186/s13008-020-00069-y.
9
Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy.氧化应激在视网膜中诱导 VEGF 自分泌环:与糖尿病视网膜病变的相关性。
Cells. 2020 Jun 11;9(6):1452. doi: 10.3390/cells9061452.
10
Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management.婴儿血管瘤普萘洛尔治疗期间无法耐受的副作用:频率、危险因素和管理。
Sci Rep. 2018 Mar 9;8(1):4264. doi: 10.1038/s41598-018-22787-8.